SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced estimated first quarter revenue of approximately $270 million. This number is based on a preliminary estimate and remains subject to review by Illumina’s independent registered public accounting firm. Analysis of the remainder of the income statement is incomplete, but the company expects non-GAAP EPS to be at […]
SAN DIEGO, CA — Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced completion of an $11.8 million Series B financing. New investors Redmile Group and Claremont Creek Ventures and private investors from Genalyte’s Series A round participated in the Series B financing. Genalyte intends to use the new […]
Männedorf, Switzerland, – The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2011 Annual Report in the Investor Relations section of the company’s website at www.tecan.com. Tecan already published its 2011 financial results in a press release and at the Press Briefing on Annual Results and Analysts’ Conference held on March […]
The JUMO group can look back at a successful financial year in 2011. For the first time JUMO has surpassed the 200 million euro threshold. JUMO Germany generated sales of 152 million euro (previous year 133 million euro). Sales growth of about 13 % was achieved worldwide. Consolidated sales rose from 179 million euro in […]
Denator AB today announced that the company has successfully completed a sixth round of financing, raising 25.5 million SEK (2,75 MEuro). Major contributions came from new investors, Novo Seeds, the early stage investment group of Novo A/S, and the venture capital company, Almi Invest. Existing investors also participated in this round of financing. In conjunction […]
Microlytic ApS announced that the company has secured USD 3.5 million in additional venture financing to expand sales and production operations in the Structural Biology sector. “Microlytic has the potential to revolutionize the process of protein crystallization by offering tools that significantly enhance success rates in crystallization, which is much needed in the industry, without […]
SAN DIEGO– Accelrys, Inc. (NASDAQ:ACCL) today reported financial results for the quarter and full year ended December 31, 2011. Non-GAAP revenue for the quarter ended December 31, 2011 decreased $1.6 million to $40.8 million from $42.5 million for the same quarter of the previous year, or a decrease of 4%. Non-GAAP revenue for the year […]
Omaha, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the year ended December 31, 2011 and provided a business update. “Transgenomic enjoyed a landmark year in 2011, with revenue growth quarter-over-quarter and year-over-year as well as an attention to expense management translating into positive modified EBITDA for both the fourth quarter and […]
Gaithersburg, Md.— OpGen, Inc., a commercial stage whole-genome analysis company, announced today that it has reached agreement with new and existing investors to raise up to $17 million in a new growth capital financing. Harris & Harris Group, Inc. and Cross Creek Capital an affiliate of Wasatch Advisors, joined existing investors Highland Capital Partners, Versant […]
PORT WASHINGTON, N.Y.,- Pall Corporation (NYSE:PLL) today reported financial results for the second quarter of fiscal year 2012 which ended on January 31, 2012. Second Quarter and Six Months Sales and Earnings Overview Second quarter sales were $698 million, an increase of 8.2% over last year. Sales in local currency (“LC”) increased 8.0%. Orders in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
